Read + Share
Amedeo Smart
Independent Medical Education
Yu EJ, Bell DW. The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-beta signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors. PLoS One 2024;19:e0312806.PMID: 39576826
Email
LinkedIn
Privacy Policy